Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Times Interest Earned (2022 - 2025)

Arrowhead Pharmaceuticals (ARWR) has disclosed Times Interest Earned for 4 consecutive years, with $1.81 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Times Interest Earned rose 124.32% year-over-year to $1.81, compared with a TTM value of $3.33 through Dec 2025, up 125.88%, and an annual FY2025 reading of $1.1, up 105.92% over the prior year.
  • Times Interest Earned was $1.81 for Q4 2025 at Arrowhead Pharmaceuticals, down from $2.03 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $17.62 in Q1 2025 and bottomed at -$34.58 in Q2 2024.
  • Average Times Interest Earned over 4 years is -$9.77, with a median of -$11.07 recorded in 2024.
  • The sharpest move saw Times Interest Earned plummeted 282.9% in 2024, then surged 201.13% in 2025.
  • Year by year, Times Interest Earned stood at -$14.79 in 2022, then tumbled by 72.03% to -$25.44 in 2023, then skyrocketed by 70.69% to -$7.46 in 2024, then skyrocketed by 124.32% to $1.81 in 2025.
  • Business Quant data shows Times Interest Earned for ARWR at $1.81 in Q4 2025, $2.03 in Q3 2025, and -$6.79 in Q2 2025.